Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa-Reference-Cited by-同舟云学术

Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa

Published:2012-05-07 Issue:14 Volume:72 Page:3522-3534
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Ng Yi-Zhen,Pourreyron Celine,Salas-Alanis Julio C.,Dayal Jasbani H.S.,Cepeda-Valdes Rodrigo,Yan Wenfei,Wright Sheila,Chen Mei,Fine Jo-David,Hogg Fiona J.,McGrath John A.,Murrell Dedee F.,Leigh Irene M.,Lane E. Birgit,South Andrew P.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-09

2. Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa;Scientific Reports;2024-08-16

3. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa–Associated Cutaneous Squamous Cell Carcinoma;Journal of Investigative Dermatology;2024-07

4. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa;British Journal of Dermatology;2024-05-31

5. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa;Human Immunology;2024-05